Leuprolide clinical trials
Also written Lupron, Leuprorelin, Lupron Depot and CKD-841.
Includes 9 studies of Luprolide acetate gel depot and 3 studies of Leuprolide mesylate.
How each study uses Leuprolide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Leuprolide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 9 Apr 1985 · LUPRON · NDA 019010 (FDA, Drugs@FDA)
- European Union
- 24 May 2022 · Camcevi · EMEA/H/C/005034 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
151 studies that test it; most in 2014 (9)
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1992 | 2 |
| 1993 | 1 |
| 1994 | 2 |
| 1996 | 2 |
| 1997 | 2 |
| 1999 | 2 |
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 8 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 7 |
| 2008 | 5 |
| 2009 | 8 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 8 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 45 · Other 108
Takeda (6) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (5) · Abbott (5) · National Cancer Institute (NCI) (3) · University of Colorado, Denver (3) · University of North Carolina, Chapel Hill (3) · GP-Pharm (3) · University of Chicago (3)
Often tested with
Tested in the same studies.
Goserelin (16) · Bicalutamide (14) · Degarelix (9) · Flutamide (8) · Triptorelin (8) · Estradiol (7) · Abiraterone (6) · Darolutamide (5)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Leuprolide is the comparator. A study of two new drugs counts under both.
- 1Linzagolix · Kissei Pharmaceutical Co., Ltd. · next primary completion Nov 2027
Reaching primary completion within a year · 12, 4 in phase 3
Studies that test Leuprolide, phase 3 first.
- Nov 2026Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical ProstatectomyPhase 3 · Ottawa Hospital Research Institute
- Nov 2026Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialPhase 3 · NRG Oncology
- Sep 2027Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.Phase 3 · UNICANCER
- Oct 2027Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapyPhase 3 · University Medical Center Groningen
- Nov 2026Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland CancersPhase 2 · National Cancer Institute (NCI)
- Dec 2026COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcerPhase 4 · Brazilian Clinical Research Institute
- Dec 2026Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate CancerPhase 2 · McGill University Health Centre/Research Institute of the McGill University Health Centre
- Jan 2027Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerPhase 2 · Jonsson Comprehensive Cancer Center
- Feb 2027Rezvilutamide for High-Risk Prostate Cancer After SurgeryNot applicable · Fujian Medical University Union Hospital
- Apr 2027Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar DefectNot applicable · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Studies
Open first, then newest update. How each study uses Leuprolide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 153
- Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)RecruitingPhase 2Ontario Clinical Oncology Group (OCOG)NCT06654336Written as ELIGARD 22.5mg
- Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CTRecruitingPhase 2Baptist Health South FloridaNCT07455903Written as Leuprolide
- A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious PubertyRecruitingPhase 4LG ChemNCT07710430Written as Leuprorelin
- Kisspeptin Administration Subcutaneously to Patients With IHHRecruitingPhase 2Stephanie B. Seminara, MDNCT05896293Written as leuprolide acetate
- Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialRecruitingPhase 2University of Michigan Rogel Cancer CenterNCT07158021Written as Leuprolide
- Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar DefectRecruitingNot applicableXinhua Hospital, Shanghai Jiao Tong University School of MedicineNCT05206682Written as Leuprorelin
- Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular TracersRecruitingPhase 2/3Cancer Research AntwerpNCT06282588Written as Depo-Eligard 45 mg
- Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate CancerRecruitingPhase 2Ohio State University Comprehensive Cancer CenterNCT06330805Written as Leuprolide
- Rezvilutamide for High-Risk Prostate Cancer After SurgeryNot yet recruitingNot applicableFujian Medical University Union HospitalNCT07444983Written as Rezvilutamide and Leuprorelin
- REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac TrialRecruitingPhase 3Emory UniversityNCT06650579Written as Leuprolide
- Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate CancerRecruitingPhase 2McGill University Health Centre/Research Institute of the McGill University Health CentreNCT04249154Written as Eligard
- Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical ProstatectomyRecruitingPhase 3Ottawa Hospital Research InstituteNCT05169112Written as Lupron Depot
- Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624RecruitingPhase 3Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología RadioterápicNCT05781217Written as triptorelin, goserelin, leuprorelin
- Evaluate the Efficacy and Safety of DWJ108JRecruitingPhase 3Daewoong Pharmaceutical Co. LTD.NCT06025409Written as Leuprolide Acetate 11.25 MG/ML
- Adenomyosis and ARTRecruitingPhase 4Azienda Ospedaliero-Universitaria di ModenaNCT05937490Written as Enantone
- A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCTNot yet recruitingNot applicableFirst Affiliated Hospital Xi'an Jiaotong UniversityNCT05667428Written as leuprorelin
- A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver DiseaseRecruitingPhase 2University Medical Center GroningenNCT05478083Written as Leuprorelin
- Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland CancersActive, not recruitingPhase 2National Cancer Institute (NCI)NCT05669664Written as Leuprolide Acetate
- Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell TumorsCompletedPhase 2National Cancer Institute (NCI)NCT06169124Written as Leuprolide Acetate
- COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcerActive, not recruitingPhase 4Brazilian Clinical Research InstituteNCT06627530Written as leuprorelin
See all 153 studies that test Leuprolide →
Given beside what is tested · 87 — Leuprolide is usual care or a partner of the new treatment
- Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingRecruitingPhase 3ECOG-ACRIN Cancer Research GroupNCT04423211Written as Leuprolide Acetate
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerRecruitingPhase 3SWOG Cancer Research NetworkNCT03678025Written as Leuprolide Acetate
- Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate CancerRecruitingPhase 2Icahn School of Medicine at Mount SinaiNCT07027124Written as Lupron
- Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE TrialRecruitingPhase 2Mayo ClinicNCT07650240Written as Leuprolide Acetate
- Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate CancerRecruitingPhase 2City of Hope Medical CenterNCT04734730Written as Leuprolide Acetate
- A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast CancerRecruitingPhase 2Gustave Roussy, Cancer Campus, Grand ParisNCT07159451Written as Leuprorelin
- Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct CarcinomaRecruitingPhase 2Peking University First HospitalNCT06348264Written as Leuprolide Acetate
- A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung CancerRecruitingNot applicableJinzhou Medical UniversityNCT06512207Written as Leuprorelin acetate + Sintilimab
- Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young WomenRecruitingPhase 3First Affiliated Hospital, Sun Yat-Sen UniversityNCT02914158Written as Leuprolide
- Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryActive, not recruitingPhase 2/3NRG OncologyNCT03070886Written as Leuprolide
- Phase IIIb Study of Ribociclib + ET in Early Breast CancerActive, not recruitingPhase 3Novartis PharmaceuticalsNCT05827081Written as Leuprolide
- Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerActive, not recruitingPhase 2/3VA Office of Research and DevelopmentNCT04787744Written as Goserelin, Histrelin, Leuprolide & Triptorelin
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerActive, not recruitingPhase 3SWOG Cancer Research NetworkNCT01674140Written as leuprolide acetate
- Neo-DAB: Darolutamide and Abemaciclib in Prostate CancerTerminatedPhase 1Praful Ravi, MB BCHir, MRCPNCT05617885Written as GNRH-A Leuprolide Acetate
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyActive, not recruitingPhase 2Astellas Pharma Global Development, Inc.NCT02960022Written as Leuprolide acetate
- Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialActive, not recruitingPhase 3NRG OncologyNCT04513717Written as Leuprolide
- Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate CancerActive, not recruitingPhase 2M.D. Anderson Cancer CenterNCT01786265Written as Leuprolide Acetate
- Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE StudyActive, not recruitingPhase 3ECOG-ACRIN Cancer Research GroupNCT04484818Written as Leuprolide Acetate
- AASUR in High Risk Prostate CancerCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT02772588Written as Leuprolide
- A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular TypingActive, not recruitingPhase 2Fudan UniversityNCT05924256Written as SHR 3680 + leuprolide
Showing 20 of 87.
As the comparator · 39 — what is tested is compared with Leuprolide
- Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisRecruitingPhase 1Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.NCT07755956Written as Enantone
- RecoverPC: Relugolix vs GnRH Agonist in Quality of LifeRecruitingPhase 2Dana-Farber Cancer InstituteNCT05765500Written as Leuprolide
- Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE TrialRecruitingPhase 2Mayo ClinicNCT06378866Written as Leuprolide
- Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RPRecruitingPhase 2Cancer Research AntwerpNCT03899077Written as Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial
- Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetateCompletedPhase 3Sumitomo Pharma America, Inc.NCT05605964Written as Leuprolide Acetate
- A Clinical Study of KLH-2109 in Patients With EndometriosisActive, not recruitingPhase 3Kissei Pharmaceutical Co., Ltd.NCT07015268Written as Leuprorelin acetate
- Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate CancerCompletedPhase 2University of Colorado, DenverNCT02278185Written as leuprolide acetate
- A Clinical Study of KLH-2109 in Uterine Fibroids Patient With MenorrhagiaCompletedPhase 3Kissei Pharmaceutical Co., Ltd.NCT05440383Written as Leuprorelin
- Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With EndometriosisCompletedEarly Phase 1Colorado Center for Reproductive MedicineNCT04445025Written as Leuprolide Acetate 3.75 MG/ML
- Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative SurgeryCompletedPhase 3Universitas DiponegoroNCT06145438Written as Leuprolide (as Leuprolide Acetate)
- A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic PainCompletedPhase 2Astellas Pharma Europe B.V.NCT01767090Written as Leuprorelin acetate
- Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer PatientsCompletedPhase 2Palleos Healthcare GmbHNCT03272477Written as Leuprorelin acetate
- Degarelix in the Treatment of Endometriosis RecurrenceCompletedPhase 3Centre for Endocrinology and Reproductive Medicine, ItalyNCT01712763Written as Leuprolide Acetate 11.25 MG/ML (Enantone 11,25)
- Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western MedicineCompletedPhase 4Children's Hospital of Fudan UniversityNCT03963752Written as Leuprorelin Acetate 3.75mg Injection
- Bay98-7196, Dose Finding / POC StudyCompletedPhase 2BayerNCT02203331Written as Lupron / Leuprolide acetate
- Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate CancerTerminatedPhase 2GTxNCT01326312Written as Lupron Depot
- A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular DiseaseTerminatedPhase 3Ferring PharmaceuticalsNCT02663908Written as Leuprolide
- A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate CancerCompletedPhase 3Myovant Sciences GmbHNCT03085095Written as Leuprolide Acetate
- Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With EndometriosisCompletedPhase 3ASKA Pharmaceutical Co., Ltd.NCT03931915Written as Leuprorelin acetate
- Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic InjectionStatus unknownPhase 4Assiut UniversityNCT04094467Written as Leuprolide Acetate
Showing 20 of 39.
What changed recently
From the registry's own updates since Oct 18, 2026.
Results posted1
Codes
What other systems call Leuprolide · ClinicalTrials.gg INT008545
- MeSH (NLM) D016729LeuprolideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) EFY6W0M8TGLEUPROLIDEConfirmed FDA, NLM, Wikidata
- RxNorm 42375Confirmed FDA, Wikidata
- Wikidata Q907160leuprolideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62042LeuprolideOne source FDA
- DrugBank DB00007One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D016729 | Leuprolide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | EFY6W0M8TG | LEUPROLIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 42375 | — | Confirmed FDA, Wikidata |
| Wikidata | Q907160 | leuprolide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62042 | Leuprolide | One source FDA |
| DrugBank | DB00007 | — | One source Wikidata |
Also registered as leuprolide acetate (UNII 37JNS02E7V · RxNorm 203217).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.